Stifel Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,537
| Closed | -$479K | – | 3399 |
|
|
2022
Q4 | $479K | Sell |
6,537
-474
| -7% | -$34.8K | ﹤0.01% | 2495 |
|
|
2022
Q3 | $532K | Sell |
7,011
-182
| -3% | -$13.8K | ﹤0.01% | 2395 |
|
|
2022
Q2 | $499K | Sell |
7,193
-95
| -1% | -$6.59K | ﹤0.01% | 2466 |
|
|
2022
Q1 | $604K | Sell |
7,288
-807
| -10% | -$66.9K | ﹤0.01% | 2469 |
|
|
2021
Q4 | $608K | Sell |
8,095
-1,984
| -20% | -$149K | ﹤0.01% | 2484 |
|
|
2021
Q3 | $1.17M | Buy |
10,079
+1,156
| +13% | +$134K | ﹤0.01% | 1965 |
|
|
2021
Q2 | $1.98M | Buy |
8,923
+858
| +11% | +$190K | ﹤0.01% | 1621 |
|
|
2021
Q1 | $1.07M | Sell |
8,065
-1,982
| -20% | -$262K | ﹤0.01% | 1946 |
|
|
2020
Q4 | $1.74M | Buy |
10,047
+1,234
| +14% | +$213K | ﹤0.01% | 1471 |
|
|
2020
Q3 | $981K | Sell |
8,813
-375
| -4% | -$41.7K | ﹤0.01% | 1647 |
|
|
2020
Q2 | $545K | Buy |
9,188
+1,094
| +14% | +$64.9K | ﹤0.01% | 1984 |
|
|
2020
Q1 | $543K | Buy |
8,094
+3,309
| +69% | +$222K | ﹤0.01% | 1811 |
|
|
2019
Q4 | $405K | Sell |
4,785
-13,657
| -74% | -$1.16M | ﹤0.01% | 2386 |
|
|
2019
Q3 | $1.38M | Sell |
18,442
-1,760
| -9% | -$132K | ﹤0.01% | 1553 |
|
|
2019
Q2 | $1.28M | Sell |
20,202
-9,010
| -31% | -$569K | ﹤0.01% | 1651 |
|
|
2019
Q1 | $1.41M | Sell |
29,212
-2,685
| -8% | -$129K | ﹤0.01% | 1450 |
|
|
2018
Q4 | $1.07M | Hold |
31,897
| – | – | ﹤0.01% | 1482 |
|
|
2018
Q3 | $1.67M | Sell |
31,897
-5,000
| -14% | -$262K | ﹤0.01% | 1359 |
|
|
2018
Q2 | $1.15M | Sell |
36,897
-17,170
| -32% | -$537K | ﹤0.01% | 1520 |
|
|
2018
Q1 | $1.18M | Sell |
54,067
-5,859
| -10% | -$128K | ﹤0.01% | 1459 |
|
|
2017
Q4 | $1.21M | Sell |
59,926
-29,540
| -33% | -$596K | ﹤0.01% | 1401 |
|
|
2017
Q3 | $1.78M | Buy |
+89,466
| New | +$1.78M | 0.01% | 1185 |
|